Hibiscus BioVentures Fund Manager Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Type

Private Equity Firm

Location

Rockville MD US

Alternative Asset Classes

Established

2019

Firm Ownership

Independent Firm

Investment Team Staff

Total Staff

Hibiscus BioVentures provides technology, capital, and people to discover therapeutic and diagnostic approaches for patients who currently have no therapeutic options. Hibiscus BioVentures utilizes its subsidiaries of Orchid Bio Advisory and Hibiscus Capital Management to provide applicable guidance and capital. The firm focuses on investments in biotechnology, pharmaceutical, and life sciences.

Asset Class	No. of Funds Currently Managed	Strategies
Private Equity	1	Early Stage: Start-up, Expansion / Late Stage, Venture (General)
Real Estate	-	-
Private Debt	-	-
Infrastructure	-	-
Natural Resources	-	-

Asset Class	No. of Funds Currently Managed	AuM	Date of AuM	Strategies
Hedge Funds	0			-

Want to see more?

Request a demo for full access to this profile.

7 Known Decision Makers

Position	Location	Asset Class
Chairman	Rockville, US	PE VC
Chief Financial Officer	Rockville, US	PE VC
Investment Consultant, Latham BioPharm Group, Part of Sia Partners	Rockville, US	PE VC
Managing Director & CEO	Rockville, US	PE VC
Principal	Rockville, US	PE

Showing 5 of 7 known decision makers at Hibiscus BioVentures

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

1 Private Capital Funds Managed

Fund Name	Vintage	Strategy	Status	Fund Structure	Closed Size (MN)	Target Size (MN)	Primary Region Focus
		Venture (General)	Raising	Commingled			North America

Showing 1 of 1 private capital fund managed by Hibiscus BioVentures